Modulation of human placental P-glycoprotein expression and activity by MDR1 gene polymorphisms
Graphical abstract
Single nucleotide polymorphisms C1236T, C3435T, and G2677T/A in the MDR1 gene are associated with reduced placental P-gp protein expression yet increased transport of P-gp substrate, paclitaxel.
Introduction
The placental ABC transporter P-glycoprotein (P-gp) decreases fetal exposure to exogenous or endogenous compounds present in the maternal circulation, by extruding those that are substrates from the fetal-to-maternal direction. A recent investigation in our laboratory utilized inside–out vesicles from human placental brush border membrane to determine P-gp activity as transport of the P-gp substrate, paclitaxel. In 200 human placentas examined, there was no correlation between P-gp protein expression and transport activity of paclitaxel [1]. Consequently, we hypothesized that genetic variation could contribute to discrepancies between observed protein expression and activity of placental P-gp.
The MDR1 gene encoding P-gp displays considerable genetic variability, with specific single nucleotide polymorphisms (SNPs) occurring at high frequencies in certain populations [2]. More than 50 SNPs in the MDR1 gene have been reported [3], and the most commonly found SNPs are C1236T, C3435T, and G2677T/A. The C1236T, C3435T, and G2677T/A SNPs are found in linkage disequilibrium in up to 49% of Chinese, Malay and Indian populations [4], [5]. Additionally, the three SNPs are in linkage disequilibrium with allele frequency of 45–55% in Whites and 5–10% in African Americans [4], [5].
Consensus on the functional consequences of MDR1 genetic variation, specifically the effect of SNPs on P-gp protein expression and transport activity in the placenta, remains unclear. In Japanese women, the G2677T/A polymorphisms were associated with lower placental P-gp expression [6]. In German mothers of Caucasian ethnicity, significantly lower P-gp expression in placentas carrying the G2677T and C3435T polymorphisms was reported [7]. Homozygous carriers of the C3435T variant allele (TT) have both reduced P-gp expression and efflux activity in human intestine and leukocytes [8], [9]. However, a study by Mölsä et al., demonstrated that the presence of C3435T and G2677T/A polymorphism did not alter the transplacental transfer of the P-gp substrate saquinavir [10]. Moreover, a meta-analysis of studies containing 1036 patients did not demonstrate a correlation between the C3435T SNP and altered pharmacokinetics of the P-gp substrate cyclosporine [11]. Several reports have implicated the C3435T and G2677T/A variant alleles with increased P-gp activity in vivo[12], [13], [14]. Studies on the consequences of the C1236T polymorphism in humans are scarce; however the TT genotype is associated with increased plasma concentrations of the P-gp substrate irinotecan in cancer patients [15]. These inconclusive findings indicate that direct measurements of P-gp transport activity and the correlation between genotype and protein expression need further investigations.
Therefore, the aim of this investigation was to determine the relationship between C1236T, C3435T, and G2677T/A polymorphisms and P-gp protein expression and transport activity. The health implication of this investigation is that P-gp protein expression and polymorphisms in MDR1 could constitute significant contributing factors to P-gp transport activity, consequently affecting placental transfer and fetal exposure to xenobiotics that are P-gp substrates.
Section snippets
Chemicals
All chemicals were purchased from Sigma-Aldrich (St. Louis, MO) unless otherwise mentioned. Paclitaxel and paclitaxel [o-benzamido-3H] (38 Ci/mmol) were purchased from Moravek Biochemicals, Inc. (Brea, CA). The anti-P-gp murine monoclonal antibodies (mAb C219) were purchased from Signet Laboratories (Dedham, MA). Actin (C-2) mouse monoclonal antibodies and goat antimouse horseradish peroxidase-conjugated antibody were purchased from Santa Cruz Biotechnology, Inc. (Santa Cruz, CA).
Clinical material
A staff of
Genotype distribution and allele frequency
Placentas from 199 term deliveries were analyzed for the C1236T, C3435T and G2677T/A triallelic polymorphism using TaqMan® Genotyping Assay and PCR-RFLP-base genotyping assay. The frequency of variant allele of the C1236T and G2677T/A SNPs differed significantly between Caucasian, African American, and Hispanic mothers. The frequency of the variant allele for the C3435T polymorphism was similar in Caucasian and Hispanic mothers, yet was significantly lower in African American mothers than in
Discussion
The goal of this investigation was to examine the relationship between MDR1 polymorphism, human placental P-gp protein expression and activity. A previous report from our laboratory [1] revealed that there was inter-individual variability and thus no correlation between the expression of P-gp protein and its activity in the transport of paclitaxel in 200 term human placentas. In order to elucidate the genetic factors contributing to the above finding, we investigated three common polymorphisms
Acknowledgements
The authors thank the Perinatal Research Division for their assistance, and the Publication, Grant, & Media Support of the UTMB Department of Obstetrics and Gynecology. Supported by the National Institute on Drug Abuse Grant DA13431 (M.S.A.).
References (27)
- et al.
Permeation of astilbin and taxifolin in Caco-2 cell and their effects on the P-gp
Int J Pharm
(2009) - et al.
Transfer of methadone across the dually perfused preterm human placental lobule
Am J Obstet Gynecol
(2008) - et al.
P-glycoprotein expression of the human placenta during pregnancy
Placenta
(2005) - et al.
Expression of the multidrug resistance P-glycoprotein (ABCB1 glycoprotein) in the human placenta decreases with advancing gestation
Placenta
(2006) - et al.
P-glycoprotein subcellular localization and cell morphotype in MDR1 gene-transfected human osteosarcoma cells
Biol Cell
(1999) - et al.
Opiates inhibit paclitaxel uptake by P-glycoprotein in preparations of human placental inside-out vesicles
Biochem Pharmacol
(2009) - et al.
P-glycoprotein: from genomics to mechanism
Oncogene
(2003) - et al.
Three hundred twenty six genetic variations in genes encoding nine members of ATP-binding cassette subfamily B (ABCB/MDR/TAP), in the Japanese population
J Hum Genet
(2002) - et al.
Functional implications of genetic polymorphisms in the multidrug resistance gene MDR1 (ABCB1)
Pharmacol Res
(2004) - et al.
Sequence diversity and haplotype structure in the human ABCB1 (MDR1, multidrug resistance transporter) gene
Pharmacogenetics
(2003)